To improve a promising cancer drug, cut it in half
A new study shows that when an experimental cancer medication is split in half, the molecule becomes safer and more effective.
Nov 11, 2022
0
55
A new study shows that when an experimental cancer medication is split in half, the molecule becomes safer and more effective.
Nov 11, 2022
0
55
Indiana University School of Medicine researchers are investigating how the deficiency of a gene in immune cells can shape the progression of Alzheimer's disease.
Nov 3, 2022
0
66
An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...
Nov 3, 2022
0
2102
Two new omicron subvariants, BQ.1 and BQ.1.1, are quickly gaining traction in the US, collectively accounting for 27% of infections as of October 29. Both are descendants of BA.5, the omicron variant that has dominated around ...
Oct 31, 2022
0
12
The total magnitude of the T-cell responses induced by mRNA and inactivated SARS-CoV-2 vaccines are comparable; however, the similarity ends here, according to a new study led by Duke-NUS Medical School scientists.
Oct 31, 2022
0
108
The protein kinase CK2 is involved in a wide range of biological processes and cellular functions, including inflammatory responses and pathologies associated with inflammation. Also, its aberrant expression and activity ...
Oct 31, 2022
0
72
Vaccines work their magic by effectively creating immune cells that are long lived, often for over decades. These immune cells create both a protective barrier that can prevent or minimize re-infection and a memory that allows ...
Oct 28, 2022
0
99
A subset of health care workers vaccinated against COVID-19 had unexpectedly low responses to the immunizations, according to Cedars-Sinai investigators. The findings of the new study are published in iScience.
Oct 26, 2022
0
55
The emergence of SARS-CoV-2 (the virus that causes COVID) has changed the world as we know it. Although new vaccines and antiviral treatments have brought hope, the pesky virus has continued to mutate and evade us.
Oct 26, 2022
0
8
Targeted therapies specifically attach to and hinder cancer-causing proteins, but cancer cells can quickly evolve to thwart their action. A second drug class, immunotherapies, harnesses the immune system to attack cancer ...
Oct 17, 2022
0
10